APOE and dementia: Also, the small number of subjects in the subgroup analyses (CDR, Fried's frailty criteria), the even smaller number of subjects for some subgroups (APOE ε4 carriers, participants with low levels of omega-3, with high risk dementia, with low MMSE score) and missing information (amyloid status) unfortunately limited further detailed analysis.